Prevention of HIV-1 infection with antiretroviral therapy [2]

New England Journal of Medicine

Volumn 365, Issue 20, 2011, Pages 1934-1935

  Tao, Xiaohua ^a   Shao, Dan ^a   Xue, Wei ^a  

^a Jiangxi Province Dermatology Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; LETTER; NONHUMAN; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; THERAPY DELAY; VIRUS LOAD; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FEMALE; MALE; NOTE;

ANTI-RETROVIRAL AGENTS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 81455135732     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1110588     Document Type: Letter

References (4)

1. Reynolds SJ, Makumbi F, Nakigozi G, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS 2011;25:473-7.
2. Shafer LA, Nsubuga RN, White R, et al. Antiretroviral therapy and sexual behavior in Uganda: a cohort study. AIDS 2011;25:671-8.
3. Hamers RL, Siwale M, Wallis CL, et al. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr 2010;55:95-101.
4. Ross L, Lim ML, Liao Q, et al. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities. HIV Clin Trials 2007;8:1-8. (Pubitemid 46542904)